Dan Dahlgren - Clorox Interim Connection
| CLX Stock | USD 169.30 0.15 0.09% |
Executive
Dan Dahlgren is Interim Connection of The Clorox
| Address | 1221 Broadway, Oakland, CA, United States, 94612-1888 |
| Phone | 510 271 7000 |
| Web | https://www.thecloroxcompany.com |
Clorox Management Efficiency
The company has Return on Asset of 0.1255 % which means that on every $100 spent on assets, it made $0.1255 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.0845 %, implying that it generated $2.0845 on every 100 dollars invested. Clorox's management efficiency ratios could be used to measure how well Clorox manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Clorox's Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.1 in 2024, whereas Return On Tangible Assets are likely to drop 0.07 in 2024. At this time, Clorox's Intangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 557.9 M in 2024, whereas Total Assets are likely to drop slightly above 4 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Gerrit Lotz | Gold Fields Ltd | N/A | |
| Joerg Koglin | Merck Company | N/A | |
| Jacob Ricciardone | Gold Fields Ltd | N/A | |
| Shashi Gupta | Amtech Systems | N/A | |
| Paul Lancaster | Amtech Systems | N/A | |
| Jongisa Magagula | Gold Fields Ltd | 42 | |
| Aasutosh Dave | FormFactor | N/A | |
| Peter Dannenbaum | Merck Company | N/A | |
| Brian JD | Madrigal Pharmaceuticals | 62 | |
| Chirfi Guindo | Merck Company | 58 | |
| Benford Mokoatle | Gold Fields Ltd | 50 | |
| Alex Howarth | Madrigal Pharmaceuticals | 55 | |
| Jennifer JD | Merck Company | 46 | |
| Chris Gratias | Gold Fields Ltd | N/A | |
| Max Combes | Gold Fields Ltd | N/A | |
| Dalton III | Merck Company | 57 | |
| Ronald Filippo | Madrigal Pharmaceuticals | N/A | |
| Mark Underwood | Madrigal Pharmaceuticals | N/A | |
| Shai CPA | FormFactor | 52 | |
| Carole Huntsman | Madrigal Pharmaceuticals | 59 | |
| Alan Chan | FormFactor | 47 | |
Management Performance
| Return On Equity | 2.08 | ||||
| Return On Asset | 0.13 |
Clorox Leadership Team
Elected by the shareholders, the Clorox's board of directors comprises two types of representatives: Clorox inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clorox. The board's role is to monitor Clorox's management team and ensure that shareholders' interests are well served. Clorox's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clorox's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Baker, Chief Accounting Officer, Corporate Controller | ||
| Lisah Burhan, Managing Director - Investor Relations | ||
| Stacey Grier, Vice President - Brand Engagement and Enhanced Wellness Marketing | ||
| Andrew Mowery, Senior Vice President Chief Product Supply Officer | ||
| Spencer Fleischer, Independent Director | ||
| Troy Datcher, Senior Vice President Chief Customer Officer | ||
| Paul Parker, Independent Director | ||
| Michael Ott, Senior Officer | ||
| Chau Banks, Senior Vice President, Chief Information and Enterprise Analytics Officer | ||
| Eric Reynolds, Executive Vice President - Cleaning and Burt's Bees | ||
| Denise Garner, Senior Vice President Chief Innovation Officer | ||
| Gina Kelly, Senior Officer | ||
| Shanique BonelliMoore, Chief VP | ||
| Kirsten Marriner, Chief People and Corporate Affairs Officer, Executive Vice President | ||
| Pamela Graham, Lead Independent Director | ||
| Rick Mcdonald, Senior Vice President Chief Product Supply Officer | ||
| Rebecca Dunphey, Group Connection | ||
| Michael Costello, Senior Vice President, General Manager - Nutranext and RenewLife | ||
| Richard Carmona, Independent Director | ||
| Laura Peck, Chief Financial Officer, Vice President, Controller | ||
| Russell Weiner, Independent Director | ||
| Matt Gregory, Senior Officer | ||
| Benno Dorer, Chairman of the Board, Chief Executive Officer | ||
| Kevin Jacobsen, Chief Financial Officer, Executive Vice President | ||
| Laura Stein, Executive Vice President, General Counsel - Corporate Affairs | ||
| Robert Matschullat, Lead Independent Director | ||
| Dan Dahlgren, Interim Connection | ||
| Angela Hilt, Senior Vice President – Chief Legal Officer | ||
| Matthew Shattock, Independent Chairman of the Board | ||
| Eric Schwartz, Senior Officer | ||
| John McNulty, Senior Vice President, Chief Information Officer | ||
| Christopher Williams, Independent Director | ||
| Linda Rendle, Executive Vice President - Strategy and Operations | ||
| Nina Barton, Executive Connection | ||
| Chris Hyder, Executive Hygiene | ||
| Pamela ThomasGraham, Lead Independent Director | ||
| Tony Matta, Executive Vice President Chief Growth Officer | ||
| Erbie Foster, Chief Officer | ||
| Esther Lee, Independent Director | ||
| Amy Banse, Independent Director | ||
| William Bailey, Senior Vice President – Corporate Business Development | ||
| Allan Mackay, Independent Director | ||
| Diego Barral, Senior Vice President General Manager - International Division | ||
| Kathryn Tesija, Director |
Clorox Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Clorox a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.08 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 23.41 B | ||||
| Shares Outstanding | 123.78 M | ||||
| Shares Owned By Insiders | 0.18 % | ||||
| Shares Owned By Institutions | 81.71 % | ||||
| Number Of Shares Shorted | 3.17 M | ||||
| Price To Earning | 45.43 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Clorox Stock Analysis
When running Clorox's price analysis, check to measure Clorox's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clorox is operating at the current time. Most of Clorox's value examination focuses on studying past and present price action to predict the probability of Clorox's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clorox's price. Additionally, you may evaluate how the addition of Clorox to your portfolios can decrease your overall portfolio volatility.